(Q35547260)

8 August 2017

1 reference

title

The therapeutic potential of interleukin-6 in treating obesity (English)

1 reference

8 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

16 March 2024

Kristina Wallenius

1

0 references

Ville Wallenius

object named as

Ville Wallenius

3

0 references

John-Olov Jansson

2

object named as

John-Olov Jansson

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14712598.3.7.1061

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Expert Opinion on Biological Therapy

16 March 2024

published in

1 reference

8 August 2017

volume

3

1 reference

8 August 2017

issue

7

1 reference

8 August 2017

page(s)

1061-1070

1 reference

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Obesity drug pipeline not so fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Muscle-derived interleukin-6: possible biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Insulin resistance and chronic cardiovascular inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Interleukin 6 and its receptor: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

The ciliary neurotrophic factor and its receptor, CNTFR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Interleukin (IL)-6 mRNA Expression is Stimulated by Insulin, Isoproterenol, Tumour Necrosis Factor Alpha, Growth Hormone, and IL-6 in 3T3-L1 Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Stimulation of interleukin-6 release by interleukin-1beta from isolated human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Effect of continuous intravenous injection of interleukin-6 and pretreatment with cyclooxygenase inhibitor on brain c-fos expression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Metabolic effects of interleukin-6 in human splanchnic and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Dose-dependent effects of recombinant human interleukin-6 on glucose regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Association between adiponectin and mediators of inflammation in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Penetration of interleukin-6 across the murine blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Genetics of body-weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Nuclear factor kappa-B and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

IL-6 transgenic mouse model for extraosseous plasmacytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1061

Medicinal strategies in the treatment of obesity

21 January 2018

12

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Intracerebroventricular interleukin-6 treatment decreases body fat in rats

16 March 2024

17

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans.

16 March 2024

21

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity

16 March 2024

25

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content.

16 March 2024

31

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Normal pharmacologically-induced, but decreased regenerative liver growth in interleukin-6-deficient (IL-6(-/-)) mice

16 March 2024

35

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Retarded Liver Growth in Interleukin-6-Deficient and Tumor Necrosis Factor Receptor-1-Deficient Mice1

16 March 2024

36

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Central nervous system control of food intake

16 March 2024

39

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Expression of immunoregulatory cytokines in neurons of the lateral hypothalamic area and amygdaloid nuclear complex of rats immunized against human IgG

16 March 2024

40

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Interleukin-6 is a centrally acting endogenous pyrogen in the rat

16 March 2024

44

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

American Journal of Physiology

16 March 2024

52

268

E813–E819

STOUTHARD JM

1995

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans

16 March 2024

56

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions

16 March 2024

67

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

Clinical trials with IL-6.

16 March 2024

72

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

A phase I trial of intravenous interleukin-6 in patients with advanced cancer.

16 March 2024

73

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1061

16 March 2024

Identifiers

1 reference

8 August 2017

1 reference